TuHURA Biosciences, Inc./NV 8-K

What Happened

• TuHURA Biosciences, Inc. filed an 8‑K on June 17, 2026 announcing its 2026 Annual Meeting will be held virtually on August 18, 2026. Because this date is more than 30 days from the anniversary of the company’s June 23, 2025 special meeting, prior deadlines under Rule 14a‑8 and the company’s proxy access and bylaw nomination timelines no longer apply. The company set new timely‑submission deadlines for shareholder proposals, proxy access director nominations, bylaw nominations, and universal proxy notices.

Key Details

• 2026 Annual Meeting date: August 18, 2026 (virtual).
• New deadline for Rule 14a‑8 shareholder proposals and for proxy access and bylaw nominations: June 27, 2026 (close of business).
• Universal proxy (Rule 14a‑19) notices for proxy contests must also be delivered by June 27, 2026.
• Submission address: TuHURA Biosciences, Inc., 10500 University Center Dr., Suite 110, Tampa, FL 33612, Attn.: Secretary. Announcements of adjournment/postponement do not restart these deadlines.

Why It Matters

• Investors or groups who want to submit proposals or nominate directors for inclusion in TuHURA’s 2026 proxy materials must meet the June 27, 2026 deadline and comply with Rule 14a‑8, the company’s Bylaws (proxy access requirements), Rule 14a‑19 and other applicable rules. Missing these deadlines means proposals or nominees likely will not be included in the company’s proxy statement or materials. The virtual format is also the mode for shareholder participation and voting.